Page last updated: 2024-11-04

gatifloxacin and Clostridium Infections

gatifloxacin has been researched along with Clostridium Infections in 5 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Clostridium Infections: Infections with bacteria of the genus CLOSTRIDIUM and closely related CLOSTRIDIOIDES species.

Research Excerpts

ExcerptRelevanceReference
"Since 2002, an epidemic of Clostridium difficile infections has occurred in southern Quebec, Canada."1.35Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. ( Béliveau, C; Labbé, AC; Laverdière, M; Louie, T; Maccannell, D; Pépin, J; Poirier, L; Savoie, M, 2008)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Labbé, AC1
Poirier, L1
Maccannell, D1
Louie, T1
Savoie, M1
Béliveau, C1
Laverdière, M1
Pépin, J1
Jump, RL1
Riggs, MM1
Sethi, AK1
Pultz, MJ1
Ellis-Reid, T1
Riebel, W1
Gerding, DN1
Salata, RA1
Donskey, CJ1
Gaynes, R1
Rimland, D1
Killum, E1
Lowery, HK1
Johnson, TM1
Killgore, G1
Tenover, FC1
Khurana, A1
Vinayek, N1
Recco, RA1
Go, ES1
Zaman, MM1
Leroi, MJ1
Siarakas, S1
Gottlieb, T1

Other Studies

5 other studies available for gatifloxacin and Clostridium Infections

ArticleYear
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Community-Acqu

2008
Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USA.
    Emerging infectious diseases, 2010, Volume: 16, Issue:5

    Topics: Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infect

2010
Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Mar-01, Volume: 38, Issue:5

    Topics: Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; D

2004
The incidence of Clostridium difficile-associated and non-C. difficile-associated diarrhea after use of gatifloxacin and levofloxacin in an acute-care facility.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Aug-15, Volume: 39, Issue:4

    Topics: Clostridioides difficile; Clostridium Infections; Diarrhea; Emergency Medical Services; Fluoroquinol

2004
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:1

    Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections;

2002